NZ712814A - Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate - Google Patents
Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitateInfo
- Publication number
- NZ712814A NZ712814A NZ712814A NZ71281411A NZ712814A NZ 712814 A NZ712814 A NZ 712814A NZ 712814 A NZ712814 A NZ 712814A NZ 71281411 A NZ71281411 A NZ 71281411A NZ 712814 A NZ712814 A NZ 712814A
- Authority
- NZ
- New Zealand
- Prior art keywords
- acid
- diquafosol
- ophthalmic solution
- producing
- same
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010291463 | 2010-12-28 | ||
NZ61252011 | 2011-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ712814A true NZ712814A (en) | 2016-08-26 |
Family
ID=56800425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ712814A NZ712814A (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ712814A (en) |
-
2011
- 2011-12-27 NZ NZ712814A patent/NZ712814A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019001253A (en) | Protein-active agent conjugates and method for preparing the same. | |
SG10201811175WA (en) | Method for treating cancer using a combination of chk1 and atr inhibitors | |
UA113839C2 (en) | EYE SOLUTION CONTAINING DICVAFOSOL, METHOD OF ITS PREPARATION AND METHOD OF INHIBITION OF NON-SOLUTION DEPOSIT | |
IN2012DN04940A (en) | ||
PH12015501964A1 (en) | Substituted 2-aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c | |
MX2013011854A (en) | Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent. | |
MX2012004210A (en) | Pyrazole derivatives as modulators of calcium release -activated calcium channel. | |
UA115532C2 (en) | Hydrazide containing nuclear transport modulators and uses thereof | |
UA106054C2 (en) | Normal;heading 1;heading 2;heading 3;SUBSTITUTED IMIDAZO[1,5-a]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS | |
MX2011008221A (en) | Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor. | |
MX350112B (en) | Furo [3, 2 - b] - and thieno [3, 2 - b] pyridine derivatives as tbk1 and ikk inhibitors. | |
MX2009005413A (en) | Crystalline forms of zoledronic acid. | |
MX2014003376A (en) | Benzoic acid derivatives as eif4e inhibitors. | |
MX2014004646A (en) | Method for inhibition of deubiquitinating activity. | |
GB2500128A (en) | Colonoscopy-preparation | |
MX359318B (en) | Compositions comprising peg and ascorbate. | |
MX2022002219A (en) | Triazolopyrimidines as a2a / a2b inhibitors. | |
NZ610378A (en) | Lipoyl compounds and their use for treating ischemic injury | |
CL2012001300A1 (en) | Process for preparing a compound of formula (i) in ionic salt form, comprising the steps of i) hydrogenating a compound of formula (ii) using a metallic catalyst with hydrogen and ii) filtering the catalyst followed by treatment with a solution acid or gas. | |
PH12016500913A1 (en) | Soap bar | |
IN2014MN01495A (en) | ||
NZ712814A (en) | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate | |
MY181555A (en) | 5?-dibenzyl phosphates of 5-azacytidine or 2?-deoxy-5-azacytidine | |
MX2014005399A (en) | Methods for treating gout in patient subpopulations. | |
MX2015017864A (en) | Preparation method for pyrrolidine-2-carboxylic acid derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ERR | Error or correction |
Free format text: THE FILED DATE HAS BEEN CORRECTED TO 27/12/2011 Effective date: 20151002 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 27 DEC 2018 BY HENRY HUGHES IP LIMITED Effective date: 20170109 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 DEC 2019 BY CPA GLOBAL Effective date: 20181115 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 DEC 2020 BY CPA GLOBAL Effective date: 20191114 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 DEC 2021 BY CPA GLOBAL Effective date: 20201112 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 27 DEC 2022 BY CPA GLOBAL Effective date: 20211111 |
|
LAPS | Patent lapsed |